BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27100709)

  • 1. Role of mitochondria, ROS, and DNA damage in arsenic induced carcinogenesis.
    Lee CH; Yu HS
    Front Biosci (Schol Ed); 2016 Jun; 8(2):312-20. PubMed ID: 27100709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of mtDNA damage elicited by oxidative stress in the arsenical skin cancers.
    Lee CH; Wu SB; Hong CH; Chen GS; Wei YH; Yu HS
    J Invest Dermatol; 2013 Jul; 133(7):1890-900. PubMed ID: 23370535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant cell proliferation by enhanced mitochondrial biogenesis via mtTFA in arsenical skin cancers.
    Lee CH; Wu SB; Hong CH; Liao WT; Wu CY; Chen GS; Wei YH; Yu HS
    Am J Pathol; 2011 May; 178(5):2066-76. PubMed ID: 21514422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic-Induced Carcinogenesis and Immune Dysregulation.
    Huang HW; Lee CH; Yu HS
    Int J Environ Res Public Health; 2019 Aug; 16(15):. PubMed ID: 31374811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant immune responses in arsenical skin cancers.
    Lee CH; Liao WT; Yu HS
    Kaohsiung J Med Sci; 2011 Sep; 27(9):396-401. PubMed ID: 21914527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial biogenesis drives tumor cell proliferation.
    Martinez-Outschoorn UE; Pavlides S; Sotgia F; Lisanti MP
    Am J Pathol; 2011 May; 178(5):1949-52. PubMed ID: 21514412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease.
    Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y
    J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 promoter -56 and -54bp CpG un-methylation predicts invasive progression in arsenic-induced Bowen's disease.
    Liao WT; You HL; Chai CY; Lee CH; Lan CE; Chang SJ; Yu CL; Yu HS
    J Dermatol Sci; 2018 Feb; 89(2):191-197. PubMed ID: 29103775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ΔNp63 promotes abnormal epidermal proliferation in arsenical skin cancers.
    Lu JH; Liao WT; Lee CH; Chang KL; Ke HL; Yu HS
    Toxicol In Vitro; 2018 Dec; 53():57-66. PubMed ID: 30026126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological dysfunction in chronic arsenic exposure: From subclinical condition to skin cancer.
    Yu S; Liao WT; Lee CH; Chai CY; Yu CL; Yu HS
    J Dermatol; 2018 Nov; 45(11):1271-1277. PubMed ID: 30144155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bowen's disease with multiple lesions caused by chronic arsenic poisoning].
    Giménez H; Agurruza JM; Martínez G; Grasa MP; Carapeto FJ
    Actas Dermosifiliogr; 1980; 71(9-10):337-42. PubMed ID: 7223522
    [No Abstract]   [Full Text] [Related]  

  • 13. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
    Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
    Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
    Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
    Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic-induced keratoses and Bowen's disease.
    Watson K; Creamer D
    Clin Exp Dermatol; 2004 Jan; 29(1):46-8. PubMed ID: 14723721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic carcinogenesis in the skin.
    Yu HS; Liao WT; Chai CY
    J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skin symptoms in chronic occupational arsenic poisoning].
    Hamada T; Horiguchi S
    Nihon Rinsho; 1977 Feb; 35(2):430-3. PubMed ID: 140255
    [No Abstract]   [Full Text] [Related]  

  • 18. Arsenical cancer of skin. Histologic study with special reference to Bowen's disease.
    Yeh S; How SW; Lin CS
    Cancer; 1968 Feb; 21(2):312-39. PubMed ID: 4952508
    [No Abstract]   [Full Text] [Related]  

  • 19. Small cell lung carcinoma and Bowen's disease 40 years after arsenic ingestion.
    Heddle R; Bryant GD
    Chest; 1983 Dec; 84(6):776-7. PubMed ID: 6315314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
    Koh E; Kondoh N; Kaihara H; Fujioka H; Kitamura K
    Eur Urol; 1989; 16(5):398-400. PubMed ID: 2776813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.